Study finds some diabetic drugs can reduce risk of Alzheimer's disease

Aug 12, 2021

New Delhi, Aug 13 (ANI): A new study has found that people taking certain drugs to lower blood sugar for type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer's disease. The findings of the study were published in the journal 'American Academy of Neurology'. The study also found people taking these drugs, called dipeptidyl peptidase-4 inhibitors, showed slower cognitive decline than people in the other two groups. In people with type 2 diabetes, the body no longer efficiently uses insulin to control blood sugar. Dipeptidyl peptidase-4 inhibitors, also known as gliptins, can be prescribed when other diabetes drugs do not work. They help control blood sugar when combined with diet and exercise.